Similar articles for PMID: 23728830

Year	Number of Results
1994	1
1997	1
1998	3
1999	1
2000	2
2001	5
2002	4
2003	4
2004	6
2005	6
2006	6
2007	8
2008	13
2009	9
2010	18
2011	16
2012	9
2013	17
2014	4
2015	9
2016	1
2017	3
2018	2
2020	4
2021	3
2022	9
2023	4
2024	0

1

Effects of ezetimibe/simvastatin 10/20 mg vs. atorvastatin 20 mg on apolipoprotein B/apolipoprotein A1 in Korean patients with type 2 diabetes mellitus: results of a randomized controlled trial.

Lee JH, Kang HJ, Kim HS, Sohn DW, Oh BH, Park YB. Lee JH, et al. Am J Cardiovasc Drugs. 2013 Oct;13(5):343-51. doi: 10.1007/s40256-013-0031-6. Am J Cardiovasc Drugs. 2013. PMID: 23728830 Clinical Trial.

2

Effects of atorvastatin 20 mg, rosuvastatin 10 mg, and atorvastatin/ezetimibe 5 mg/5 mg on lipoproteins and glucose metabolism.

Her AY, Kim JY, Kang SM, Choi D, Jang Y, Chung N, Manabe I, Lee SH. Her AY, et al. J Cardiovasc Pharmacol Ther. 2010 Jun;15(2):167-74. doi: 10.1177/1074248409357922. Epub 2010 Feb 10. J Cardiovasc Pharmacol Ther. 2010. PMID: 20147603 Clinical Trial.

3

Ezetimibe/simvastatin vs atorvastatin in patients with type 2 diabetes mellitus and hypercholesterolemia: the VYTAL study.

Goldberg RB, Guyton JR, Mazzone T, Weinstock RS, Polis A, Edwards P, Tomassini JE, Tershakovec AM. Goldberg RB, et al. Mayo Clin Proc. 2006 Dec;81(12):1579-88. doi: 10.4065/81.12.1579. Mayo Clin Proc. 2006. PMID: 17165637 Clinical Trial.

4

Pitavastatin: novel effects on lipid parameters.

Chapman MJ. Chapman MJ. Atheroscler Suppl. 2011 Nov;12(3):277-84. doi: 10.1016/S1567-5688(11)70887-X. Atheroscler Suppl. 2011. PMID: 22152282 Review.

5

Achievement of specified low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol apolipoprotein B, and high-sensitivity C-reactive protein levels with ezetimibe/simvastatin or atorvastatin in metabolic syndrome patients with and without atherosclerotic vascular disease (from the VYMET study).

Robinson JG, Ballantyne CM, Hsueh W, Rosen J, Lin J, Shah A, Lowe RS, Hanson ME, Tershakovec AM. Robinson JG, et al. J Clin Lipidol. 2011 Nov-Dec;5(6):474-82. doi: 10.1016/j.jacl.2011.06.004. Epub 2011 Jun 15. J Clin Lipidol. 2011. PMID: 22108151 Clinical Trial.

6

Age, abdominal obesity, and baseline high-sensitivity C-reactive protein are associated with low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B responses to ezetimibe/simvastatin and atorvastatin in patients with metabolic syndrome.

Robinson JG, Ballantyne CM, Hsueh WA, Rosen JB, Lin J, Shah AK, Tomassini JE, Lowe RS, Tershakovec AM. Robinson JG, et al. J Clin Lipidol. 2013 Jul-Aug;7(4):292-303. doi: 10.1016/j.jacl.2013.03.007. Epub 2013 Apr 3. J Clin Lipidol. 2013. PMID: 23890516 Clinical Trial.

7

The efficacy and safety of ezetimibe/simvastatin combination compared with intensified lipid-lowering treatment strategies in diabetic subjects with and without metabolic syndrome.

Jimenez JG, Rosen JB, Pirags V, Massaad R, Hanson ME, Brudi P, Triscari J. Jimenez JG, et al. Diabetes Obes Metab. 2013 Jun;15(6):513-22. doi: 10.1111/dom.12059. Epub 2013 Jan 25. Diabetes Obes Metab. 2013. PMID: 23279632 Clinical Trial.

8

Atorvastatin 10 mg plus ezetimibe 10mg compared with atorvastatin 20 mg: impact on the lipid profile in Japanese patients with abnormal glucose tolerance and coronary artery disease.

Uemura Y, Watarai M, Ishii H, Koyasu M, Takemoto K, Yoshikawa D, Shibata R, Matsubara T, Murohara T. Uemura Y, et al. J Cardiol. 2012 Jan;59(1):50-6. doi: 10.1016/j.jjcc.2011.09.001. Epub 2011 Nov 17. J Cardiol. 2012. PMID: 22100058 Free article. Clinical Trial.

9

Changes in LDL-C levels and goal attainment associated with addition of ezetimibe to simvastatin, atorvastatin, or rosuvastatin compared with titrating statin monotherapy.

Foody JM, Toth PP, Tomassini JE, Sajjan S, Ramey DR, Neff D, Tershakovec AM, Hu H, Tunceli K. Foody JM, et al. Vasc Health Risk Manag. 2013;9:719-27. doi: 10.2147/VHRM.S49840. Epub 2013 Nov 15. Vasc Health Risk Manag. 2013. PMID: 24265554 Free PMC article.

10

Cholesterol-lowering effects of rosuvastatin compared with atorvastatin in patients with type 2 diabetes -- CORALL study.

Wolffenbuttel BH, Franken AA, Vincent HH; Dutch Corall Study Group. Wolffenbuttel BH, et al. J Intern Med. 2005 Jun;257(6):531-9. doi: 10.1111/j.1365-2796.2005.01499.x. J Intern Med. 2005. PMID: 15910557 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

153 results

Results by year